Journal article
Effect of Different Doses of Acetylsalicylic Acid on the Antithrombotic Activity of Clopidogrel in a Mouse Arterial Thrombosis Model
Abstract
Objective- Dual-antiplatelet therapy with acetylsalicylic acid and a P2Y12 antagonist, such as clopidogrel, is the standard of care for acute coronary syndromes. However, the drugs have divergent effects on the formation of cAMP, an inhibitory second messenger. Thus, by inhibiting the synthesis of prostacyclin, acetylsalicylic acid reduces cAMP formation, whereas clopidogrel potentiates it. Therefore, with higher doses of acetylsalicylic acid, …
Authors
Ni R; Vaezzadeh N; Zhou J; Weitz JI; Cattaneo M; Gross PL
Journal
Arteriosclerosis Thrombosis and Vascular Biology, Vol. 38, No. 10, pp. 2338–2344
Publisher
Wolters Kluwer
Publication Date
October 2018
DOI
10.1161/atvbaha.118.311404
ISSN
1079-5642
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
6-Ketoprostaglandin F1 alphaAnimalsArterial Occlusive DiseasesAspirinBlood PlateletsClopidogrelCyclic AMPDisease Models, AnimalDose-Response Relationship, DrugDrug InteractionsDrug Therapy, CombinationFibrinolytic AgentsMaleMice, Inbred C57BLPlatelet AggregationPlatelet Aggregation InhibitorsThrombosis